Compare Adaptive Biotechnologies Corp (ADPT) vs Toronto-Dominion Bank (TD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Toronto-Dominion Bank — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Toronto-Dominion Bank trades at $121.35 (market cap $200.48B). The key difference: Toronto-Dominion Bank is far larger — about 49.6× Adaptive Biotechnologies Corp's market cap, and Toronto-Dominion Bank pays a 2.63% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | TD | |
|---|---|---|
Market Cap | $4.04B | $200.48B |
Sector | Health | Financials |
52-Week High | $25.45 | $124.80 |
52-Week Low | $12.30 | $72.85 |
Enterprise Value | $4.10B | — |
Dividend Yield | — | 2.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Toronto-Dominion Bank
Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.
Read more on TD →
